Andrew H. Sims

8.0k citations

127 papers · 4.9k indexed · 1 hit paper · h-index 39

Molecular Biology top 2%
Oncology top 1%
Cancer Research top 1%
Immunology top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Robert B. Clarke J. Michael Dixon Anthony Howell David J. Harrison Çiğdem Selli Göran Landberg Richard R. Meehan Arran Turnbull
Topics: Cancer Cells and Metastasis (26 papers)Breast Cancer Treatment Studies (25 papers)Estrogen and related hormone effects (18 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Nature Communications
Partner nations: United Kingdom United States Italy

In The Last Decade

Andrew H. Sims

126 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA–DNA triplex structures

2015 511 citations Andrew H. Sims et al. profile →

Peers

Countries citing papers authored by Andrew H. Sims

Since Specialization

Citations

This map shows the geographic impact of Andrew H. Sims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew H. Sims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew H. Sims more than expected).

Fields of papers citing papers by Andrew H. Sims

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew H. Sims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew H. Sims. The network helps show where Andrew H. Sims may publish in the future.

Co-authorship network of co-authors of Andrew H. Sims

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew H. Sims. A scholar is included among the top collaborators of Andrew H. Sims based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew H. Sims. Andrew H. Sims is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells 2023 ·Oncogene ·Fuhui Chen,(unknown),David Novo,Çiğdem Selli,Denis Alférez,(unknown),Kyriaki Pavlou,Jingwei Zhang,Andrew H. Sims,Neil Humphreys,Antony Adamson,Andrew D. Campbell,Owen J. Sansom,Cathy Tournier,Robert B. Clarke,Keith Brennan,Charles Streuli,Ahmet Uçar	8
2	Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy 2021 ·Clinical Cancer Research ·(unknown),Stephen F. Madden,James Hawley,Sara Charmsaz,Çiğdem Selli,Katherine M. Sheehan,Leonie S. Young,Andrew H. Sims,Pavel Souček,Arnold D. Hill,Marie McIlroy	5
3	Elevated EDAR signalling promotes mammary gland tumourigenesis with squamous metaplasia 2021 ·Oncogene ·R. H. Williams,(unknown),Andrew H. Sims,Chunyan Mou,(unknown),Giovanna M. Collu,Charles Streuli,Andrew Gilmore,Denis J. Headon,Keith Brennan	9
4	Activation of the S100A7/RAGE Pathway by IGF-1 Contributes to Angiogenesis in Breast Cancer 2021 ·Cancers ·(unknown),Marianna Talia,Rosamaria Lappano,Andrew H. Sims,Veronica Vella,Francesca Cirillo,Livia Manzella,(unknown),Marcello Maggiolini,Antonino Belfiore,(unknown)	33
5	Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells 2021 ·Cells ·Veronica Vella,(unknown),Alessandro La Ferlita,Michele Pellegrino,Germano Gaudenzi,Salvatore Alaimo,Michele Massimino,Alfredo Pulvirenti,Alessandra Dicitore,Paolo Vigneri,Giovanni Vitale,Roberta Malaguarnera,Andrea Morrione,Andrew H. Sims,Alfredo Ferro,Marcello Maggiolini,Rosamaria Lappano,Ernestina Marianna De Francesco,Antonino Belfiore	17
6	Breast cancer gene expression datasets do not reflect the disease at the population level 2020 ·npj Breast Cancer ·(unknown),Brittny C. Davis Lynn,(unknown),David Cameron,Jonine D. Figueroa,Andrew H. Sims	8
7	The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 2020 ·Cells ·Marianna Talia,(unknown),Damiano Cosimo Rigiracciolo,(unknown),(unknown),Antonino Belfiore,Marcello Maggiolini,Andrew H. Sims,Rosamaria Lappano	37
8	Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth 2020 ·The Journal of Experimental Medicine ·Ruoyu Ma,Hui Zhang,Xuefeng Li,Chengbin Zhang,Çiğdem Selli,(unknown),(unknown),Sandrine Prost,Andrew H. Sims,Haiyan Hu,Tianlei Ying,Zhan Wang,Zhaoming Ye,Jeffrey W. Pollard,Bin‐Zhi Qian	115
9	Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer 2019 ·Molecular Cancer Therapeutics ·Márcia A. Inda,Erik J. Blok,Peter J.K. Kuppen,Ayoub Charehbili,(unknown),(unknown),(unknown),Elma Meershoek‐Klein Kranenbarg,Susan L. Kloet,Bart van der Burg,John W.M. Martens,Andrew H. Sims,Arran Turnbull,J. Michael Dixon,Wim Verhaegh,Judith R. Kroep,Cornelis J.�H. van de Velde,Anja van de Stolpe	39
10	Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors 2018 ·Cancer Immunology Research ·Ajit J. Nirmal,Tim Regan,Barbara Shih,David Hume,Andrew H. Sims,Tom C. Freeman	135
11	Kindlin-1 Promotes Pulmonary Breast Cancer Metastasis 2018 ·Cancer Research ·(unknown),Hitesh Patel,(unknown),(unknown),(unknown),Morwenna Muir,Jocelyn Ward,John C. Dawson,Martin Lee,Jayne Culley,Donald M. Salter,Andrew H. Sims,Adam Byron,Valerie G. Brunton	19
12	Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer 2018 ·Clinical Cancer Research ·(unknown),Damir Varešlija,Sara Charmsaz,Ailís Fagan,(unknown),Nicola Cosgrove,Sinéad Cocchiglia,(unknown),Lance Hudson,Sudipto Das,Darran P. O’Connor,Philip J. O’Halloran,Andrew H. Sims,Arnold D. Hill,Leonie S. Young	17
13	MCL-1 is a prognostic indicator and drug target in breast cancer 2018 ·Cell Death and Disease ·Kirsteen J. Campbell,Sandeep Dhayade,Nicola Ferrari,Andrew H. Sims,Emma Johnson,Susan Mason,(unknown),Kevin M. Ryan,Gabriela Kalna,Joanne Edwards,Stephen W. G. Tait,Karen Blyth	144
14	Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors 2016 ·Clinical Cancer Research ·Damir Varešlija,Jean McBryan,Ailís Fagan,Aisling M. Redmond,Hao Yuan,Andrew H. Sims,Arran Turnbull,J. Michael Dixon,Peadar Ó Gaora,Lance Hudson,(unknown),Arnold D. Hill,Leonie S. Young	17
15	Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance 2015 ·Cancer Research ·Susann Busch,Andrew H. Sims,Olle Stål,Mårten Fernö,Göran Landberg	22
16	Molecular Changes in Lobular Breast Cancers in Response to Endocrine Therapy 2014 ·Cancer Research ·Laura Arthur,Arran Turnbull,(unknown),Alexey A. Larionov,Lorna Renshaw,Charlene Kay,Jeremy Thomas,J. Michael Dixon,Andrew H. Sims	25
17	Engineering a synthetic cell panel to identify signalling components reprogrammed by the cell growth regulator anterior gradient-2 2014 ·Molecular BioSystems ·(unknown),(unknown),Euan Murray,Andrew H. Sims,Ted R. Hupp	15
18	Low PIP4K2B Expression in Human Breast Tumors Correlates with Reduced Patient Survival: A Role for PIP4K2B in the Regulation of E-Cadherin Expression 2013 ·Cancer Research ·Willem‐Jan Keune,Andrew H. Sims,D. I. Jones,Yvette Bultsma,James T. Lynch,Karin Jirström,Göran Landberg,Nullin Divecha	40
19	FRMD4A Upregulation in Human Squamous Cell Carcinoma Promotes Tumor Growth and Metastasis and Is Associated with Poor Prognosis 2012 ·Cancer Research ·Stephen J. Goldie,Klaas W. Mulder,David Wei‐Min Tan,Scott K. Lyons,Andrew H. Sims,Fiona M. Watt	46
20	Biomarkers of Dietary Energy Restriction in Women at Increased Risk of Breast Cancer 2009 ·Cancer Prevention Research ·Kai Ren Ong,Andrew H. Sims,Michelle Harvie,Mary Ann Chapman,Warwick B. Dunn,David Broadhurst,Royston Goodacre,Mary Wilson,(unknown),Robert B. Clarke,Anthony Howell	39

About Andrew H. Sims

Andrew H. Sims is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 127 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (26 papers), Breast Cancer Treatment Studies (25 papers) and Estrogen and related hormone effects (18 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.8k citations) and Molecular Biology (3.0k citations). Andrew H. Sims has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robert B. Clarke, J. Michael Dixon, Anthony Howell, David J. Harrison, Çiğdem Selli, Göran Landberg, Richard R. Meehan, Arran Turnbull, Sacha J. Howell and Simon P. Langdon. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact